The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.
Sponsor
Kafrelsheikh University (Other)
Overall Status
Completed
CT.gov ID
NCT05231252
Collaborator
(none)
10
1
7
1.4
Study Details
Study Description
Brief Summary
Transcleral cyclophotocoagulation has been used to treat glaucoma secondary to silicone oil
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
10 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
pilotpilot
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.
Actual Study Start Date
:
Jun 1, 2021
Actual Primary Completion Date
:
Jan 1, 2022
Actual Study Completion Date
:
Jan 1, 2022
Outcome Measures
Primary Outcome Measures
- IOP lowering in patients with silicon induced glaucoma [6 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
1- Patients above 18 years of age. 2- silicon filled for more than 2 months. 3- IOP more than 21 mmHg on triple topical antiglaucoma eye drops.
Exclusion Criteria: 1- history of glaucoma prior to the initial retinal surgery. 2- Immediate rise of IOP after SOI. 3- History of previous laser application to the ciliary body. 4- Any contraindications for silicone oil removal.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ain Shams University | Cairo | Egypt | 11771 |
Sponsors and Collaborators
- Kafrelsheikh University
Investigators
- Study Director: Ahmed A.Mohamed, PhD, Ain Shams University,Faculty of medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ahmed Hashiem,
Ahmed Osama Hashem,
Kafrelsheikh University
ClinicalTrials.gov Identifier:
NCT05231252
Other Study ID Numbers:
- 27-12-22
First Posted:
Feb 9, 2022
Last Update Posted:
Feb 9, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms: